In a recently published decision of April 22, 2015 (file no 5/12 Qs 1/15), the district court in Frankfurt am Main ruled that bribing the managing director of a limited liability company is not a criminal offense under Section 299 German Criminal Code, if the managing director is also the…
In a noteworthy trend picked-up by Trace International’s Global Enforcement Report, in 2014 non-U.S. enforcement actions concerning bribery of…
We asked Mini vandePol (Head of the Baker & McKenzie Global and Asia-Pacific Compliance Practice Group) and Joanna Ludlam…
On April 27, 2015, Transparency International UK (“TIUK”) released the Defense Companies Anti-Corruption Index 2015 (the “Index”). The Index, which was first released in October 2012 and now updated for the first time since then, assesses the transparency and quality of the ethics and anti-corruption compliance programs of 163 defense…
In August 2014, the Federal Court of Justice handed down a recently publish decision in connection with the…
We rarely think about emergencies before they arrive on our doorstep. Yet, the recent civil unrest in Baltimore…
The Dutch competition authority (“ACM”) has recently published a paper setting out its strategy and enforcement priorities relating to vertical agreements. The paper is available in English: https://www.acm.nl/en/publications/publication/14226/ACMs-strategy-and-enforcement-priorities-with-regard-to-vertical-agreements/ The paper (re)confirms ACM’s lenient economic approach towards vertical restraints: ACM assumes that vertical restraints are generally pro-competitive in the absence of market power. This…
The European Commission’s Digital Single Market (“DSM”) agenda was launched on May 6, 2015 combining a wide ranging…
Effectively managing corporate compliance efforts in today’s regulatory environment–preventing corporate officers and employee from engaging in illegal practices,…
The German Federal Ministry of Justice (Bundesministerium der Justiz und für Verbraucherschutz) proposed a draft bill which extends corruption legislation to independent healthcare professionals. On March 29, 2012 the German Federal Supreme Court had to decide the following case (file no. GSSt 2/11): A medical representative of a pharma company…